Price History
PI Industries' earnings disappoint, causing a decline in its shares, while Mankind Pharma experiences growth due to strong earnings. Meanwhile, Godawari Power, Karnataka Bank, and Dredging Corp have all seen an increase in their shares, following robust results.
Karnataka Bank has announced a final dividend of ₹5 per share, marking a positive move towards returning value to its shareholders.
Karnataka Bank achieved a new high in net profit for FY26, reaching INR 1,310 crores, marking an impressive growth of 5.1% year-on-year in total business to INR 1,92,118.7 crores. Notably, the bank's GNPA has been reduced to 2.8%, demonstrating a positive trend in loan performance.
Karnataka Bank has reported a significant 62% year-on-year increase in profit for Q4, reaching ₹408 crores, largely due to an upsurge in Net Interest Income (NII) by approximately 9% to ₹843 crores.
Karnataka Bank's Q4 profits experienced a substantial 62% increase compared to the previous year, alongside improved asset quality. The board has proposed a final dividend of Rs. 5 per share, enhancing returns for shareholders.
Karnataka Bank reported a net profit of ₹1,310.5 crore for the fiscal year ending March 31, 2026, as per their audited results. The bank's board proposed a dividend of ₹5 per share, subject to shareholder approval, and affirmed an unmodified opinion on their financial statements by the auditors.
Karnataka Bank shows an impressive 8% growth in loans quarter-on-quarter, reaching Rs. 83,340 crore. The bank also reports a significant decrease of 54 basis points in GNPA to 2.78%, with CASA deposits rising by 11% to Rs. 36,560 crore. This positive development demonstrates the bank's successful growth and improvement in asset quality.
Karnataka Bank shows a significant improvement in its asset quality during Q4 as the GNPA drops to 2.78%, down from 3.32% in the previous quarter. Additionally, the NNPA also improved, falling to 0.98% compared to 1.31% in the last quarter, indicating a positive trend for the bank's financial health.
Karnataka Bank experienced a significant 10% increase in shares today, reaching an intraday high of ₹271.4, following strong Q4 results. The bank reported a 40% quarter-on-quarter increase in net profit to ₹408.2 crore for FY26, and a yearly profit of ₹1,310.5 crore. Shareholders can also look forward to a ₹5 dividend per share. The bank's CASA ratio improved to 33.6%, while gross advances grew by 8% quarter-on-quarter.
Based on recent financial analysis, Karnataka Bank Ltd has received a 'Buy' recommendation from MarketsMojo as of March 2026. The bank's current standing suggests a promising investment opportunity, as per the latest metrics evaluated on May 17, 2026.
Karnataka Bank experienced a 1.87% drop to Rs.242, with the stock underperforming the Sensex's decline by 1.31%, following a period of profit-taking after hitting its 52-week high and amidst broader market weakness.
According to the latest rating by MarketsMojo, Karnataka Bank is currently a recommended buy, as of the analysis dated 25th April 2026.
Karnataka Bank has teamed up with Pine Labs to strengthen their Point-of-Sale (PoS) offerings for retail and small-medium enterprises (MSMEs), aiming for growth. The bank's stock price finished at ₹251.01 on NSE, marking a daily increase of 0.28%. Over the past year, shares have seen a significant surge of 27.7%.
Karnataka Bank recently issued bonds worth INR 300 crores on March 30, 2022, offering a yearly interest rate of 10.7%. These bonds also include a call option that becomes effective five years into the loan term.
Karnataka Bank has been granted an exception from SEBI's mandatory filings for large corporations, effective until the fiscal year ending in March 2026, as stated in SEBI's April 2022 circular.
Karnataka Bank has successfully listed a new ₹300 crore Non-Convertible Debenture (NCD) on the National Stock Exchange (NSE). The debt instruments have been given a 'Stable A' rating by both CareEdge and ICRA, indicating a strong creditworthiness.
Despite the broader market sell-off, Lupin, Sun Pharma, Torrent Pharma, CCL Products, and Karnataka Bank show remarkable resilience due to robust fundamentals like steady growth, strong pipelines, and strategic moves. Their performance suggests a potential for long-term leadership.
Karnataka Bank's share price dropped by 6%, trading at ₹217, following the release of Q4FY26 results. Despite a 7% year-on-year advance growth in the quarter, investors may be concerned about the bank's performance.
Karnataka Bank has announced a 4% year-on-year increase in deposits and a 7% year-on-year growth in advances for Q4, indicating steady expansion in both areas.
Karnataka Bank reports a 10% year-on-year increase in Current Account Savings Account (CASA) deposits, reaching ₹36,621 crore by the end of FY26. The bank's total deposits also grew by 3.8%, and gross advances expanded by 6.9% YoY, signaling steady growth in its financial position.
Karnataka Bank has successfully paid a Rs. 32.1 crore annual interest on its Tier II Bonds (INE614B08054), with no delays or compliance issues reported under SEBI regulations, as confirmed by the exchange.